Is VRTX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-22, Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 73/100 at a spot price of $520.66 (-2.94% 1D, market cap $132.01B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 11/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 14/20, and Executive Insider Alignment 15/20. Across 1015 tracked Health Care issuers, VRTX ranks #31 in composite RQD confidence.